We started by assessing CSPG4 mRNA expression level by utilizing a publicly available database (accession number GSE126698) [20] which includes human samples of anaplastic thyroid cancer (ATC), follicular thyroid carcinoma (FTC), papillary thyroid carcinoma (PTC), and normal thyroid tissues as control. This evidence concerns the gene CSPG4 and differentiated thyroid carcinoma.